Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-22

Clinical Trial Update: Institutional Registry of Haemorrhagic Hereditary Telangiectasia

View source ↗

Summary

An update on a recruiting registry for hereditary hemorrhagic telangiectasia, sponsored by Hospital Italiano de Buenos Aires.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Hospital Italiano de Buenos Aires | Conditions: Haemorrhagic Hereditary Telangiectasia | Status: RECRUITING